☆ 4.6 Article

Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Related references

Note: Only part of the references are listed.

Article Immunology

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity

Vincent Legros et al.

Summary: The study investigated the neutralizing antibody response in serum samples from 140 confirmed SARS-CoV-2 infections, finding that antibody titers correlated with disease severity and anti-spike IgG levels. Post-recovery, patients' nAb activity declined more rapidly compared to individuals infected with other coronaviruses, and previous infection by human coronaviruses did not generate protective nAbs against SARS-CoV-2. Additionally, the D614G mutation in the spike protein did not lead to neutralization escape.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

Kate M. Bubar et al.

Summary: The study found that prioritizing the vaccine for adults aged 20 to 49 can minimize the number of cases, while prioritizing the vaccine for adults over 60 can minimize mortality and years of life lost. Redirecting vaccine doses to seronegative individuals through individual-level serological tests can improve the impact of each dose.

SCIENCE (2021)

Add to Collection

Review Hematology

COVID-19 convalescent plasma: Interim recommendations from the AABB

Claudia S. Cohn et al.

TRANSFUSION (2021)

Add to Collection

Article Virology

SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays

Gregory J. Walker et al.

Summary: Serological testing for SARS-CoV-2-specific antibodies plays a crucial role in understanding COVID-19 prevalence, incidence, and immune response. The study found a strong correlation between neutralising antibodies and certain commercially available EIAs, indicating their potential use in assessing protection post-infection or vaccination, and in screening convalescent plasma donors. The type of antibody and target antigen used in the assays were identified as crucial determinants of assay performance.

VIRUSES-BASEL (2021)

Add to Collection

Article Microbiology

Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection

Julien Favresse et al.

Summary: This study investigated the temporal dynamic changes of immune response after SARS-CoV-2 infection in hospitalized and non-hospitalized symptomatic patients over a 10-month period. Six different analytical kits were used to detect SARS-CoV-2 antibodies, showing a high inter-methodology variability. Total antibody assays had higher positivity rates and reached peak positivity rates sooner compared to IgG assays, with better inter-assay agreement between them. Stratification by disease severity revealed a much-elevated serological response in hospitalized patients. The waning effect of serological response reported in some studies may depend on the assay used.

MICROORGANISMS (2021)

Add to Collection

Letter Medicine, General & Internal

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications

Salim S. Abdool Karim et al.

Summary: The emergence of SARS-CoV-2 variants, including B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351), and P.1 (B.1.1.28.1), has raised concerns about worsening Covid-19 and potential escape from vaccine-induced immunity.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Microbiology

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers

Eshan U. Patel et al.

Summary: Accurate serological assays are crucial for detecting SARS-CoV-2 antibodies, but commercial EIAs may not always accurately detect high nAb titers in individuals, indicating the limitations of current diagnostic methods for COVID-19 convalescent plasma donation.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Article Medical Laboratory Technology

Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics

Andrea Padoan et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Ruiyun Li et al.

SCIENCE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat et al.

NATURE MEDICINE (2020)

Add to Collection

Letter Medical Laboratory Technology

Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice

Mario Plebani et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Add to Collection

Article Immunology

The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

Lakshmanane Premkumar et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction

Chee Wah Tan et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Letter Medical Laboratory Technology

Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer

Andrea Padoan et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Add to Collection

Article Microbiology

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients

Larry L. Luchsinger et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Humoral Immune Response to SARS-CoV-2 in Iceland

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Maheshi N. Ramasamy et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity

Andrea Padoan et al.

EBIOMEDICINE (2020)

Add to Collection

Letter Medical Laboratory Technology

Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity

Andrea Padoan et al.

CLINICA CHIMICA ACTA (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.